What are Michael Cavalier’s direct Cinemark (CNK) share holdings after the reported transaction?

Following the September 1, 2026 activity, Michael Cavalier is reported to hold 42,273 shares of Cinemark (CNK) common stock directly, in addition to his indirect holdings through the Cavalier Revocable Trust.

Was Michael Cavalier’s Cinemark (CNK) share disposition made under a Rule 10b5-1 plan?

Yes. The filing indicates the transaction was made pursuant to a Rule 10b5-1 trading plan, meaning the disposition was executed under a pre-arranged trading program rather than being initiated at discretion on the trade date.

Cinemark counsel sells 107K shares at $35.02

Q: What transaction did CNK executive Michael Cavalier report on this Form 4?

Michael Cavalier, EVP–General Counsel of CNK, reported an indirect disposition to the issuer of 107,296 shares of Cinemark common stock on September 1, 2026 through the Cavalier Revocable Trust.

Q: What is the relationship of Michael Cavalier to Cinemark (CNK)?

Michael Cavalier is disclosed as an officer of Cinemark (CNK), serving as EVP–General Counsel, and is the reporting person for the indirect disposition and reported holdings on this Form 4.

EVP–General Counsel Michael Cavalier reported a Rule 10b5-1 planned disposition of Cinemark shares to the issuer while retaining both indirect and direct holdings.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cinemark Holdings, Inc. (CNK) insider Michael Cavalier, EVP–General Counsel, reported an indirect disposition to the issuer of 107,296 shares of common stock on September 1, 2026 through the Cavalier Revocable Trust at a weighted average sale price of $35.02 per share, under a Rule 10b5-1 trading plan. Following this transaction, the trust held 223,385 shares indirectly and Cavalier also held 42,273 shares directly.

Insights

Analyzing...

Insider Trade Summary 10b5-1

Disposition: 107,296 shares

Disposition 2 txns

Insider Cavalier Michael

Role EVP-General Counsel

Type	Security	Shares	Price	Value
Disposition	Common Stock ^F1	107,296	$35.02	$3.76M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 223,385 shares (Indirect, Cavalier Revocable Trust); Common Stock — 42,273 shares (Direct)

Footnotes (1)

F1. The reported price per share is the weighted average sale price for the shares.

Key Figures

Shares disposed indirectly: 107,296 shares Weighted average sale price: $35.02 per share Indirect holdings after transaction: 223,385 shares +2 more

5 metrics

Shares disposed indirectly 107,296 shares Disposition to issuer on September 1, 2026 via Cavalier Revocable Trust

Weighted average sale price $35.02 per share Price for the 107,296-share disposition on September 1, 2026

Indirect holdings after transaction 223,385 shares Cavalier Revocable Trust position following the reported disposition

Direct holdings after transaction 42,273 shares Direct Cinemark common stock held by Michael Cavalier as of September 1, 2026

Transaction date September 1, 2026 Date of the disposition to issuer and updated holdings

Key Terms

Disposition to issuer, weighted average sale price, Rule 10b5-1 trading plan

3 terms

Disposition to issuer financial

"reported an indirect disposition to the issuer of 107,296 shares"

weighted average sale price financial

"at a weighted average sale price of $35.02 per share"

Rule 10b5-1 trading plan regulatory

"transaction was made pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

What transaction did CNK executive Michael Cavalier report on this Form 4?

Michael Cavalier, EVP–General Counsel of CNK, reported an indirect disposition to the issuer of 107,296 shares of Cinemark common stock on September 1, 2026 through the Cavalier Revocable Trust.

At what price were the Cinemark (CNK) shares disposed of by Michael Cavalier’s trust?

The Cavalier Revocable Trust’s disposition of Cinemark (CNK) shares occurred at a weighted average sale price of $35.02 per share, as disclosed for the September 1, 2026 transaction.

How many Cinemark (CNK) shares does Michael Cavalier hold indirectly after this Form 4 transaction?

After the reported transaction, the Cavalier Revocable Trust held 223,385 shares of Cinemark (CNK) common stock indirectly associated with Michael Cavalier, according to the Form 4 disclosure.

What is the relationship of Michael Cavalier to Cinemark (CNK)?

Michael Cavalier is disclosed as an officer of Cinemark (CNK), serving as EVP–General Counsel, and is the reporting person for the indirect disposition and reported holdings on this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 04:16 PM Accepted by SEC EDGAR 09/03/2026 - 04:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cavalier Michael

(Last)

(First)

(Middle)

3900 DALLAS PARKWAY

(Street)

PLANO

TEXAS

75093

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP-General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/01/2026		D		107,296	D	$35.02⁽¹⁾	223,385	I	Cavalier Revocable Trust
Common Stock								42,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reported price per share is the weighted average sale price for the shares.

	/s/ Michael Cavalier attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR